COVID-19: Keep up to date with the latest pharmaceutical and healthcare news as the pandemic evolves

Space invaders

Next-generation cell and gene therapies are spurring demand for manufacturing space in key life sciences clusters
The rise of patient 2.0

Janssen’s Emily Bone talks about modern patient engagement evolution and why it is the driving force for a brave new era

News

View all

Verona’s ensifentrine meets primary endpoint

Chronic obstructive pulmonary disease phase 3 study shows statistically significant improvements in lung function

9th August 2022

Arecor granted European patents to protect Humira formulations

Patents show potential of innovative Arestat technology and the development of enhanced formulations

9th August 2022

SyneuRx reveals results of COVID-19 candidate trial

Positive data show Pentarlandir is safe and effective in patients with mild-to-moderate COVID-19

8th August 2022

EQRx announces further results from phase 3 trial of sugemalimab

Study involved patients with locally advanced, unresectable stage 3 non-small cell lung cancer

8th August 2022

South Tees NHS Trust reaches e-prescribing milestone by implementing Alcidion

Better Meds is already removing paper forms and manual processes from NHS Trust’s system

5th August 2022

Web Exclusives

View all

Group therapy

Sharon King talks about her experience of bringing up a child with Batten disease and the team approach needed to develop gene therapies for rare diseases

INTCR 2022 Winners Announced

The winners of the 2022 International Clinical Researcher of the Year have been announced.

Patient Partnership Index 2022 awards Gold to seven UK and global partnerships

Celebrating and showcasing the top examples of partnerships between pharmaceutical companies and patient groups, the Patient Partnership Index 2022 results have today been announced – with seven companies awarded GOLD for their partnership work in patient advocacy, engagement and communications.

2022 Marketer of the Year competition has launched!

Celebrating and uncovering exceptional pharma marketing talent for nearly three decades, the 2022 Marketer of the Year competition has launched!

Magazine

View more from the latest edition

Vision for diversity

As we enter a new era of inclusivity are we really doing enough to improve health equity in clinical trials?

Whole new world

Modern pharma is increasingly about the applying real-world evidence to gene therapies

Stark similarities

How biosimilars support sustainability throughout global healthcare systems and deliver the building blocks for vital healthcare

Be patient

Awareness raising is key to boosting patient involvement and engendering trust

Back to life

The 2022 International Clinical Researcher of the Year awards recognised our industry’s incredible array of talent – in person!

Our imagination

One year on from the launch of the Government’s Life Sciences Vision there is a unique opportunity for the UK to become a genuine industry superpower.

A quiet revolution?

Though barely mentioned in the NHS reform debate, some major changes to Specialised Commissioning are on the way

Tomorrow’s world

As a new era for pharma begins to unfold life sciences pioneers are changing their environments

Thought Leadership

View all

Market forces

Mapping the next generation of life sciences talent

Orphan Drug Development

Rare diseases (RDs) or orphan diseases, by definition, are conditions that affect a small number of individuals. The exact number of RDs is unknown, but it is estimated to be approximately 6000-8000.

Just-in-time Labeling: Short-term Fix Or Long-term Fixture For Clinical Trials?

Despite Just-In-Time (JIT) production often being the preferred approach in clinical trial supply, it has taken a global pandemic for many organizations to make it a reality. Now, as we look to the future, PRISYM ID’s Bob Bowdish explains why these practices may be here to stay.

Native advertising is exploding across healthcare, have you jumped in?

In the last 2 years, and accelerated by Covid, native advertising has exploded across healthcare for DTC and HCP marketing. Native ads have been adopted by all healthcare industries including pharma, device, health systems, retailers, pharmacies, payers, and the gamut of regional service providers. But there are still a handful of advertiser holdouts, and they are missing out on highly engaged audiences.

Webinars

View all

Diversity in Pharma: The Impact of COVID-19 on DE&I

Thursday, 23 June 2022 - 3:00 pm

COVID-19 has had a huge impact on how we all think and act. Our working environments may look very different now to the way they did pre-pandemic, and not all the changes have been negative.

Andrés López Castaño, Tricia Lucas-Clarke, Noor Shaker, Sandra Van de Cauter, Marsha N. Ganthier

FREE | REGISTER NOW

Patient Perspectives to Improve Retention with eConsent

Tuesday, 22 February 2022 - 4:00 pm

With Tufts reporting that the average number of patient dropouts for clinical trials remains near 30%, it is clear that there is still much to be done towards improving retention¹.

Andrew Mackinnon, Digital Trial Operations Lead, Medable

FREE | ATTEND

Focusing on Patient-centricity for the Future of Pharma

Wednesday, 21 July 2021 - 2:00 pm

In healthcare, the patient voice is arguably the most important. Services and care work best when a person’s needs are fully met and they feel heard, respected and valued.

Mark Doyle, co-founder of The Method and creator of A Life in a Day

FREE | ATTEND